Amylyx Pharmaceuticals (AMLX) Q1 2025 Earnings

Mar 4Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.75
-1.17
-0.59
-0

Details

Expected EPS
-0.52
Actual EPS
-0.55
Surprise EPS
-0.03
Surprise Percent
-5.77%

Description

⁨Amylyx Pharmaceuticals⁩ (⁦AMLX⁩) has reported earnings of ⁦-0.55⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts